67 related articles for article (PubMed ID: 24416997)
21. Resistance to chemotherapy is associated with fibroblast growth factor receptor 4 up-regulation.
Roidl A; Berger HJ; Kumar S; Bange J; Knyazev P; Ullrich A
Clin Cancer Res; 2009 Mar; 15(6):2058-66. PubMed ID: 19240166
[TBL] [Abstract][Full Text] [Related]
22. FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.
Xu W; Li Y; Wang X; Chen B; Wang Y; Liu S; Xu J; Zhao W; Wu J
Eur J Cancer; 2010 Dec; 46(18):3332-8. PubMed ID: 20638838
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K
Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
25. ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.
Choi KY; Rho YS; Kwon KH; Chung EJ; Kim JH; Park IS; Lee DJ
Cancer Biomark; 2012-2013; 12(3):115-24. PubMed ID: 23481570
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor receptor 4 Gly388 Arg polymorphism is not associated with pre-eclampsia in Turkish women.
Gunes EG; Pinarbasi E
J Obstet Gynaecol Res; 2011 Dec; 37(12):1824-7. PubMed ID: 21827571
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
[TBL] [Abstract][Full Text] [Related]
28. FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.
Spinola M; Leoni VP; Tanuma J; Pettinicchio A; Frattini M; Signoroni S; Agresti R; Giovanazzi R; Pilotti S; Bertario L; Ravagnani F; Dragani TA
Oncol Rep; 2005 Aug; 14(2):415-9. PubMed ID: 16012724
[TBL] [Abstract][Full Text] [Related]
29. The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes.
Ezzat S; Zheng L; Florez JC; Stefan N; Mayr T; Hliang MM; Jablonski K; Harden M; Stančáková A; Laakso M; Haring HU; Ullrich A; Asa SL
Cell Metab; 2013 Jun; 17(6):929-940. PubMed ID: 23747250
[TBL] [Abstract][Full Text] [Related]
30. PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma.
Marshall AD; van der Ent MA; Grosveld GC
Mol Carcinog; 2012 Oct; 51(10):807-15. PubMed ID: 21882254
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures.
Cool S; Jackson R; Pincus P; Dickinson I; Nurcombe V
Int J Dev Biol; 2002; 46(4):519-23. PubMed ID: 12141439
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
Ho HK; Pok S; Streit S; Ruhe JE; Hart S; Lim KS; Loo HL; Aung MO; Lim SG; Ullrich A
J Hepatol; 2009 Jan; 50(1):118-27. PubMed ID: 19008009
[TBL] [Abstract][Full Text] [Related]
33. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract][Full Text] [Related]
34. Adrenal Corticomedullary Mixed Tumor Associated With the
Kanzawa M; Fukuoka H; Yamamoto A; Suda K; Shigemura K; Hara S; Imagawa N; Tsukamoto R; Aoyama Y; Nakamura Y; Fujisawa M; Ogawa W; Takahashi Y; Itoh T
J Endocr Soc; 2020 Sep; 4(9):bvaa101. PubMed ID: 32803097
[TBL] [Abstract][Full Text] [Related]
35. Combined effect of menopause age and genotype on occurrence of breast cancer risk in Pakistani population.
Javed S; Ali M; Sadia S; Aslam MA; Masood AI; Shaikh RS; Sayyed AH
Maturitas; 2011 Aug; 69(4):377-82. PubMed ID: 21684697
[TBL] [Abstract][Full Text] [Related]
36. Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer.
Ye YW; Hu S; Shi YQ; Zhang XF; Zhou Y; Zhao CL; Wang GJ; Wen JG; Zong H
Oncol Rep; 2013 Dec; 30(6):2777-84. PubMed ID: 24126887
[TBL] [Abstract][Full Text] [Related]
37. Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease.
Chen Q; Jiang Y; An Y; Zhao N; Zhao Y; Yu C
Biochem Biophys Res Commun; 2011 Jun; 409(4):651-6. PubMed ID: 21616061
[TBL] [Abstract][Full Text] [Related]
38. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
Cornish EE; Natoli RC; Hendrickson A; Provis JM
Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
[TBL] [Abstract][Full Text] [Related]
39. Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas.
Mawrin C; Kirches E; Diete S; Wiedemann FR; Schneider T; Firsching R; Kropf S; Bogerts B; Vorwerk CK; Krüger S; Dietzmann K
Cancer Lett; 2006 Aug; 239(2):239-45. PubMed ID: 16198476
[TBL] [Abstract][Full Text] [Related]
40. Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineage.
Yu SJ; Zheng L; Ladanyi M; Asa SL; Ezzat S
Clin Cancer Res; 2004 Oct; 10(19):6750-8. PubMed ID: 15475466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
